Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0470-2017

Drug recall · February 15, 2017

Pantoprazole Sodium for Injection recall

Why: Discoloration: Some vials were found to contain powder with a yellowish-brownish appearance.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Pantoprazole Sodium for Injection, 40mg per vial, Single-dose vial, Rx only, Mfd. in India for: Auromedics Pharma LLC 6 Wheeling Road, Dayton, NJ 08810, NDC 55150-202-00

Lots / codes

Lot #: CPO160028, Exp. June 2018

Quantity
29800 vials
Company
Aurobindo Pharma USA Inc, Plainsboro, NJ
Distribution
Nationwide in US
Initiated
December 16, 2016 · Voluntary: Firm initiated
Classified
February 8, 2017
Reported
February 15, 2017
Ended
July 29, 2020
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Pantoprazole

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.